Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

Genera Biosystems
ASX:GBI

Genera Biosystems

Health Care

Genera Biosystems Limited (GBI) is a molecular diagnostics company that develops, manufactures and distributes multiplexed molecular diagnostics (MDx) test solutions which are based on patented Ampasand silica bead based testing platform. Its first products developed using its proprietary Ampasand platform are PapType, and RTIplex, that are registered and sold in Australia and the EU. Former Names --

Read more

Market Cap

Price at Close

4w avg. Volume

-

4w avg. Turnover

-

Announcements

We don't have access to this information yet.

Market Data

We don’t have access to this information yet.

ASX:GBI

Genera Biosystems

Health Care

Genera Biosystems Limited (GBI) is a molecular diagnostics company that develops, manufactures and distributes multiplexed molecular diagnostics (MDx) test solutions which are based on patented Ampasand silica bead based testing platform. Its first products developed using its proprietary Ampasand platform are PapType, and RTIplex, that are registered and sold in Australia and the EU. Former Names --

Read more

Market Cap

Price at Close

4w avg. Volume

-

4w avg. Turnover

-

ASX:GBI is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.